220 related articles for article (PubMed ID: 22450391)
41. Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment?
Dayer JM; Krane SM
N Engl J Med; 2002 May; 346(18):1399-400. PubMed ID: 11986415
[No Abstract] [Full Text] [Related]
42. Treatment of spondyloarthritis beyond TNF-alpha blockade.
Van den Bosch F; Deodhar A
Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):819-27. PubMed ID: 25488787
[TBL] [Abstract][Full Text] [Related]
43. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
[TBL] [Abstract][Full Text] [Related]
44. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
Gaspersic N; Sersa I; Jevtic V; Tomsic M; Praprotnik S
Ann Rheum Dis; 2008 Sep; 67(9):1354. PubMed ID: 18697784
[No Abstract] [Full Text] [Related]
45. Therapy for ankylosing spondylitis: new treatment modalities.
Braun J; Breban M; Maksymowych WP
Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):631-51. PubMed ID: 12406431
[TBL] [Abstract][Full Text] [Related]
46. Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers.
Savastano M; Marioni G; Giacomelli L; Ramonda R; Ferraro SM; Punzi L
B-ENT; 2010; 6(3):183-8. PubMed ID: 21090160
[TBL] [Abstract][Full Text] [Related]
47. Switching anti-TNF therapy in ankylosing spondylitis.
Pradeep DJ; Keat AC; Gaffney K; Brooksby A; Leeder J; Harris C
Rheumatology (Oxford); 2008 Nov; 47(11):1726-7. PubMed ID: 18782856
[No Abstract] [Full Text] [Related]
48. [The pharmacotherapy of spondyloarthritis].
Curković B
Reumatizam; 2011; 58(2):65-8. PubMed ID: 22232952
[TBL] [Abstract][Full Text] [Related]
49. The role of secukinumab in the treatment of ankylosing spondylitis.
Shah R; Perry L; Deodhar A
Immunotherapy; 2015; 7(12):1241-7. PubMed ID: 26595091
[TBL] [Abstract][Full Text] [Related]
50. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.
Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Mar; 46(3):439-41. PubMed ID: 17255137
[TBL] [Abstract][Full Text] [Related]
51. Evidence in support of the validity of the TNF brake hypothesis.
Maksymowych WP
Ann Rheum Dis; 2013 Dec; 72(12):e31. PubMed ID: 23989987
[No Abstract] [Full Text] [Related]
52. Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
Van den Bosch F; De Keyser F; Mielants H; Veys EM
Arthritis Res Ther; 2005; 7(3):121-3. PubMed ID: 15899063
[TBL] [Abstract][Full Text] [Related]
53. Ankylosing spondylitis.
Braun J; Sieper J
Lancet; 2007 Apr; 369(9570):1379-1390. PubMed ID: 17448825
[TBL] [Abstract][Full Text] [Related]
54. An overview of investigational new drugs for treating ankylosing spondylitis.
Wendling D
Expert Opin Investig Drugs; 2016; 25(1):95-104. PubMed ID: 26561014
[TBL] [Abstract][Full Text] [Related]
55. New treatment targets for axial spondyloarthritis.
Sieper J
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii38-ii42. PubMed ID: 27856659
[TBL] [Abstract][Full Text] [Related]
56. Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease.
Song IH; Haibel H; Poddubnyy D; Braun J; Sieper J
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S37-42. PubMed ID: 24129135
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.
Braun J; Baraliakos X; Heldmann F; Kiltz U
Expert Opin Investig Drugs; 2014 May; 23(5):647-59. PubMed ID: 24654630
[TBL] [Abstract][Full Text] [Related]
58. Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure.
Benucci M; Damiani A; Bandinelli F; Grossi V; Infantino M; Manfredi M; Gobbi FL; Sarzi-Puttini P; Atzeni F
Isr Med Assoc J; 2018 Feb; 20(2):119-122. PubMed ID: 29431309
[No Abstract] [Full Text] [Related]
59. [Use of TNF inhibition therapy in patients with axial spondyloarthritis].
Kiltz U
Z Rheumatol; 2015 Apr; 74(3):263-4. PubMed ID: 25518965
[No Abstract] [Full Text] [Related]
60. ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Zochling J; van der Heijde D; Burgos-Vargas R; Collantes E; Davis JC; Dijkmans B; Dougados M; Géher P; Inman RD; Khan MA; Kvien TK; Leirisalo-Repo M; Olivieri I; Pavelka K; Sieper J; Stucki G; Sturrock RD; van der Linden S; Wendling D; Böhm H; van Royen BJ; Braun J; ;
Ann Rheum Dis; 2006 Apr; 65(4):442-52. PubMed ID: 16126791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
